Similar articles

• [Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].

  Horibe M. Horibe M. Nihon Yakurigaku Zasshi. 1968 Mar;64(2):159-85. Nihon Yakurigaku Zasshi. 1968. PMID: 4972692 Japanese. No abstract available.
• [Pharmacological studies on the effects of Thalamonal, a neuroleptanalgesic, on the central nervous system].

  Sakai Y, Iwata N, Mori M, Nishijima Y. Sakai Y, et al. Nihon Yakurigaku Zasshi. 1971 Sep;46(5):431-51. Nihon Yakurigaku Zasshi. 1971. PMID: 5168892 Japanese. No abstract available.
• The effects of psilocybin on EEG and behaviour in monkeys.

  Horibe M. Horibe M. Act Nerv Super (Praha). 1974 Mar;16(1):40-2. Act Nerv Super (Praha). 1974. PMID: 4454934 No abstract available.
• Central nervous system actions of some synthetic tetrahydrocannabinol derivatives.

  Domino EF, Hardman HF, Seevers MH. Domino EF, et al. Pharmacol Rev. 1971 Dec;23(4):317-36. Pharmacol Rev. 1971. PMID: 5003209 Review. No abstract available.
• Central action of normetanephrine effect on the behavior of rats.

  Kruszewska A. Kruszewska A. Acta Physiol Pol. 1975 Nov-Dec;26(6):583-90. Acta Physiol Pol. 1975. PMID: 1108596 Review. No abstract available.